YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Corticosteroid Injection in the Treatment of a Huge-Size Central Giant Cell Granuloma in Children: a Case Report

dc.authorid Keskin Tunc, Serap/0000-0001-5439-6598
dc.authorscopusid 56954780800
dc.authorscopusid 58803420800
dc.authorscopusid 6602105825
dc.authorwosid Keskin Tunc, Serap/Kcx-9207-2024
dc.contributor.author Tunc, Serap Keskin
dc.contributor.author Efe, Nihat
dc.contributor.author Ertas, Umit
dc.date.accessioned 2025-05-10T17:23:54Z
dc.date.available 2025-05-10T17:23:54Z
dc.date.issued 2024
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Tunc, Serap Keskin] Univ Hlth Sci, Fac Hamidiye Dent, Oral & Maxillofacial Surg Dept, Istanbul, Turkiye; [Efe, Nihat] Van Yuzuncu Yil Univ, Fac Dent, Oral & Maxillofacial Surg Dept, Van, Turkiye; [Ertas, Umit] Ataturk Univ, Fac Dent, Oral & Maxillofacial Surg Dept, Erzurum, Turkiye en_US
dc.description Keskin Tunc, Serap/0000-0001-5439-6598 en_US
dc.description.abstract Central giant cell granulomas (CGCGs) of the jaw are benign intraosseous and osteolytic lesions. Their clinical presentation includes atypical aggressive lesions that cause severe damage early in life, and aggressive treatment is necessary in most cases to prevent recurrence. Curettage is the most preferred therapy, but in recent years, conservative therapy is also commonly used. Corticosteroid injection treatment, a conservative method, was planned for a developing male patient with difficulty in diagnosis and treatment due to the complications of resection. After clinical and radiologic evaluation of the patient, incisional biopsy was performed and the diagnosis of SDHG was made. The patient was treated with intralesional corticosteroids once a week for eight weeks. Since the patient 's treatment was interrupted for 2 months due to the Covid-19 outbreak, 2 doses of intralesional corticosteroid (Sinakort-A 40 mg) were administered and the patient was followed up. At 12 months, clinical and panoramic radiographic examination revealed no pathologic findings related to the lesion. In this article, we report a pediatric case of giant CGCG successfully treated with intralesional corticosteroid injection. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.doi 10.1016/j.pdj.2023.12.005
dc.identifier.endpage 54 en_US
dc.identifier.issn 0917-2394
dc.identifier.issn 1880-3997
dc.identifier.issue 1 en_US
dc.identifier.scopus 2-s2.0-85181833602
dc.identifier.scopusquality Q3
dc.identifier.startpage 49 en_US
dc.identifier.uri https://doi.org/10.1016/j.pdj.2023.12.005
dc.identifier.uri https://hdl.handle.net/20.500.14720/11024
dc.identifier.volume 34 en_US
dc.identifier.wos WOS:001224688100001
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Corticosteroid en_US
dc.subject Central Giant Cell Granuloma en_US
dc.subject Children en_US
dc.title Corticosteroid Injection in the Treatment of a Huge-Size Central Giant Cell Granuloma in Children: a Case Report en_US
dc.type Article en_US

Files